Search

Myron Arlen Phones & Addresses

  • 600 Northern Blvd, Great Neck, NY 11021 (516) 487-9454
  • Barnegat, NJ
  • Riviera Beach, FL
  • Manahawkin, NJ
  • Toms River, NJ
  • Elmont, NY
  • Palm Beach, FL
  • 5540 N Ocean Dr APT 6A, West Palm Bch, FL 33404 (561) 281-2379

Work

Company: North Shore University Hospital Sgcl ONC Address: 600 Northern Blvd Suite 111, Great Neck, NY 11021 Phones: (516) 487-9454

Education

School / High School: SUNY Downstate Medical Center College Of Medicine 1957

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: General Surgery, 1963

Specialities

General Surgery

Professional Records

Medicine Doctors

Myron Arlen Photo 1

Dr. Myron Arlen, Great Neck NY - MD (Doctor of Medicine)

View page
Specialties:
General Surgery
Address:
North Shore University Hospital Sgcl ONC
600 Northern Blvd Suite 111, Great Neck, NY 11021
(516) 487-9454 (Phone)
Conditions:
Breast Cancer
Breast Lump/Mass
Carcinoma in Situ
Liver Cancer
Pancreatic Cancer
Certifications:
General Surgery, 1963
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
SUNY Downstate Medical Center College Of Medicine
Graduated: 1957
Medical School
Jewish Hospital
Graduated: 1958
Medical School
Jewish Hospital
Graduated: 1962
Medical School
Meml Hospital Sloan Kettering I
Graduated: 1965
Medical School
Meml Sloan Kettering Cancer
Graduated: 1965
Myron Arlen Photo 2

Myron Arlen

View page
Specialties:
Surgical Oncology
Work:
Northwell Health Physician PartnersNorth Shore University Hospital Surgical Oncology
450 Lakeville Rd, New Hyde Park, NY 11042
(516) 487-9454 (phone), (516) 487-2745 (fax)
Education:
Medical School
SUNY Downstate Medical Center College of Medicine
Graduated: 1957
Languages:
Chinese
English
Spanish
Description:
Dr. Arlen graduated from the SUNY Downstate Medical Center College of Medicine in 1957. He works in New Hyde Park, NY and specializes in Surgical Oncology. Dr. Arlen is affiliated with North Shore University Hospital and Saint Francis Hospital The Heart Center.
Myron Arlen Photo 3

Myron Arlen, Great Neck NY

View page
Specialties:
Surgery
Work:
North Shore Surgical Oncology
600 Northern Blvd, Great Neck, NY 11021
Education:
State University of New York Downstate (1957)
Myron Arlen Photo 4

Myron Arlen, Great Neck NY

View page
Specialties:
Surgeon
Address:
600 Northern Blvd, Great Neck, NY 11021
Education:
State University of New York Downstate Medical Center, College of Medicine - Doctor of Medicine
Memorial Sloan-Kettering Cancer Center - Fellowship - Surgical Oncology
Interfaith Medical Center - Residency - Surgery
Board certifications:
American Board of Surgery Certification in Surgery

Public records

Vehicle Records

Myron Arlen

View page
Address:
81 Wensley Dr, Great Neck, NY 11020
Phone:
(516) 487-9670
VIN:
1G6DD67V290105634
Make:
CADILLAC
Model:
STS
Year:
2009

Business Records

Name / Title
Company / Classification
Phones & Addresses
Myron Arlen
Medical Doctor, Oncology, President
Northshore Surgical Oncology Associates PC
Surgical Oncology
600 Northern Blvd, Great Neck, NY 11021
450 Lakeville Rd, New Hyde Park, NY 11042
(516) 487-9454
Myron Arlen
Surgical Oncologist
Steven E Rubin
Medical Doctor's Office · Medical Doctor's Office General Hospital
600 Northern Blvd, Great Neck, NY 11021
(516) 465-8444, (516) 465-8412
Myron Arlen
Myron Arlen MD
Oncology · Surgeons
600 Northern Blvd, Great Neck, NY 11021
(516) 487-9454
Myron Arlen
Founder
ISRAEL CANCER RESEARCH FUND INC
Fund Raising Org
295 Madison Ave SUITE 1030, New York, NY 10017
1290 Ave Of The Americas, New York, NY 10104
1290 Ave Of The Amer, New York, NY 10104
(212) 969-9800

Publications

Us Patents

Monoclonal Antibodies Against Human Colon Carcinoma-Associated Antigens And Uses Therefor

View page
US Patent:
RE39760, Aug 7, 2007
Filed:
Aug 4, 2000
Appl. No.:
09/633034
Inventors:
Kwong Y. Tsang - Bethesda MD, US
Myron Arlen - Great Neck NY, US
Assignee:
International Bio-Immune Systems Inc. - Great Neck NY
International Classification:
G01N 33/574
G01N 33/53
C07K 16/30
C07K 16/18
US Classification:
435 723, 435 71, 435 72, 435 4051, 435 4052, 435325, 435328, 435329, 435330, 435332, 435344, 5303888, 5303871, 5303873, 5303875, 5303877, 5303881, 5303911, 5303913, 5303917
Abstract:
Monoclonal antibodies, in particular 33. 28 and 31. 1, and chimeric antibodies, in particular mouse/humans chimeric Chi #1 specific for glycoprotein antigens of colon carcinoma-associated antigens which are immunogenic in humans, are disclosed. Such antibodies, and fragments and derivatives thereof, are useful in immunodiagnosis and immunotherapy of human colon, breast, and ovarian cancer, and for purification of antigens which can serve as immunotherapeutic agents. Methods of detecting the colon carcinoma-associated antigen in a sample, and methods for treating subjects having colon, breast, and ovarian carcinomas are disclosed.

Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic Cancers

View page
US Patent:
7314622, Jan 1, 2008
Filed:
Apr 14, 2006
Appl. No.:
11/404566
Inventors:
Myron Arlen - Great Neck NY, US
J. Andrew Bristol - Bethesda MD, US
Ariel C. Hollinshead - Charlotte Harbor FL, US
Kwong Y. Tsang - Bethesda MD, US
Assignee:
Neogenix Oncology, Inc. - Rockville MD
International Classification:
A61K 39/00
A61K 39/395
G01N 33/574
C07K 16/00
C07H 21/04
US Classification:
4241551, 4241331, 4241381, 435 723, 5303883
Abstract:
The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.

Identification And Development Of Specific Monoclonal Antibodies To Squamous Cell Carcinoma

View page
US Patent:
7491801, Feb 17, 2009
Filed:
Aug 28, 2001
Appl. No.:
10/363095
Inventors:
Myron Arlen - Great Neck NY, US
Kwong Y. Tsang - Bethesda MD, US
Assignee:
International Bioimmune Systems, Inc. - Great Neck NY
International Classification:
C07K 16/00
C12P 21/08
US Classification:
5303871, 5303873, 5303881, 5303888
Abstract:
The present invention relates to novel antibodies, antibody fragments and antibody conjugates which display a high degree of selectivity for squamous cell carcinoma antigens including carcinomas of the lung, esophagus and cervix. The present invention relates to both in vivo and in vitro clinical screening methods for diagnosis or prognosis of carcinomas by means of detecting the expression of squamous cell carcinoma antigens in biological samples of the subject using the novel antibodies of the invention. The invention further provides for kits for carrying out the above described screening methods. Additionally, antibody conjugates may be used to efficiently deliver various agents which have anti-tumor effects to the tumor cell. The antibodies of the invention may also be administered to a patient in non-conjugated form to target ADCC to the tumor cell.

Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic Cancers

View page
US Patent:
7763720, Jul 27, 2010
Filed:
Dec 17, 2007
Appl. No.:
12/000701
Inventors:
Myron Arlen - Great Neck NY, US
J. Andrew Bristol - Bethesda MD, US
Ariel C. Hollnshead - Charlotte Harbor FL, US
Kwong Y. Tsang - Bethesda MD, US
Assignee:
Neogenix Oncology, Inc. - Rockville MD
International Classification:
C07H 21/00
US Classification:
536 2353
Abstract:
The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.

Monoclonal Antibody Therapy For Pancreas Cancer

View page
US Patent:
8470326, Jun 25, 2013
Filed:
Jan 21, 2011
Appl. No.:
13/011485
Inventors:
Myron Arlen - Great Neck NY, US
Kwong Tsang - Bethesda MD, US
Assignee:
Precision Biologics - Rockville MD
International Classification:
A61K 39/395
US Classification:
4241551, 4241301, 4241331, 4241351, 4241381, 4241411, 4241431, 4241521, 4241561, 4241721, 4241741
Abstract:
The present invention relates to the use of binding equivalents of monoclonal antibody 31. 1, including chimerized and/or humanized versions thereof, antibody fragments as well as competitively binding and co-specific antibodies and antibody fragments, in the treatment of pancreatic cancer.

Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic Cancers

View page
US Patent:
8535667, Sep 17, 2013
Filed:
Jun 28, 2010
Appl. No.:
12/825022
Inventors:
Myron Arlen - Great Neck NY, US
J. Andrew Bristol - Bethesda MD, US
Ariel C. Hollinshead - Charlotte Harbor FL, US
Kwong Y. Tsang - Bethesda MD, US
Assignee:
Precision Biologics, Inc. - Dallas TX
International Classification:
A61K 39/395
C07K 16/18
G01N 33/53
A61P 35/00
US Classification:
4241331, 435 71, 5303873, 53038885, 5303913
Abstract:
The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.

Monoclonal Antibody Therapy For Pancreas Cancer

View page
US Patent:
20060228363, Oct 12, 2006
Filed:
Sep 22, 2005
Appl. No.:
11/234645
Inventors:
Myron Arlen - Great Neck NY, US
Kwong Tsang - Bethesda MD, US
International Classification:
A61K 39/395
C07H 21/04
C12P 21/06
C07K 16/30
US Classification:
424155100, 536023530, 435069100, 435338000, 530388800, 435320100
Abstract:
The present invention relates to the use of binding equivalents of monoclonal antibody 31.1, including chimerized and/or humanized versions thereof, antibody fragments as well as competitively binding and co-specific antibodies and antibody fragments, in the treatment of pancreatic cancer.

Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic Cancers

View page
US Patent:
20110158902, Jun 30, 2011
Filed:
Jan 24, 2011
Appl. No.:
13/012679
Inventors:
Myron ARLEN - Great Neck NY, US
J. Andrew Bristol - Bethesda MD, US
Ariel C. Hollinshead - Charlotte Harbor FL, US
Kwong Y. Tsang - Bethesda MD, US
Assignee:
NEOGENIX ONCOLOGY, INC. - Rockville MD
International Classification:
A61K 51/00
C07K 16/18
C07K 17/00
A61K 39/395
A61K 38/19
A61P 35/00
US Classification:
424 111, 5303888, 5303873, 5303872, 5303917, 5303913, 4241561, 424 851
Abstract:
The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.

Isbn (Books And Publications)

Atlas of Bone Pathology: With Clinical and Radiographic Correlations

View page
Author

Myron Arlen

ISBN #

0397510772

Surgical Management of Soft Tissue Sarcomas

View page
Author

Myron Arlen

ISBN #

0721613993

Myron Arlen from Great Neck, NY, age ~50 Get Report